Target intelligence / Profile preview

Glutamate and gamma-aminobutyric acid receptors (GluR/GABAR)

Target
GluR/GABAR
Molecular classification
Ion channel, G protein-coupled receptor, Receptor
01

Overview

Glutamate and gamma-aminobutyric acid (GABA) receptors are the primary mediators of excitatory and inhibitory neurotransmission in the vertebrate central nervous system, respectively. Glutamate receptors are divided into ionotropic receptors (NMDA, AMPA, and kainate), which are ligand-gated ion channels, and metabotropic receptors (mGluRs), which are G protein-coupled receptors (StatPearls, 2023). GABA receptors are similarly divided into the ionotropic GABA-A receptor, which primarily conducts chloride ions to hyperpolarize neurons, and the metabotropic GABA-B receptor (NIH, 2022). The balance between these two systems, often referred to as the E/I balance, is critical for maintaining physiological brain states and supporting cognitive functions like learning and memory. Dysregulation of this balance is a hallmark of numerous neurological and psychiatric conditions, including epilepsy, anxiety disorders, and neurodegenerative diseases (PubMed, 2021). Therapeutic strategies involve modulating these receptors using agonists, antagonists, or allosteric modulators to restore normal signaling, though such interventions must carefully manage risks like sedation or excitotoxicity (PubChem, 2024).

Other names
GluR and GABARExcitatory and inhibitory amino acid receptorsGlutamate and gamma-aminobutyric acid receptor systems
02

Mechanism of action

Modulation of excitatory and inhibitory synaptic transmission through agonism, antagonism, or allosteric regulation of ionotropic and metabotropic receptors (StatPearls, 2023; PubChem, 2024).

03

Biological functions

Excitatory neurotransmissionInhibitory neurotransmissionSynaptic plasticityLong-term potentiationLong-term depressionNeuronal homeostasis
04

Disease associations

EpilepsyAnxietySchizophreniaAlzheimer's diseaseParkinson's diseaseMajor depressive disorderChronic painInsomnia
05

Safety considerations

SedationRespiratory depressionExcitotoxicityCognitive impairmentSeizure riskTolerance and dependence
06

Interacting drugs

Ketamine

9 more in the full profile.

07

Biomarkers

GABA and Glutamate levels via Magnetic Resonance Spectroscopy (MRS)Receptor occupancy via Positron Emission Tomography (PET)Electroencephalography (EEG) power spectra

Beyond the preview

Go deeper on Glutamate and gamma-aminobutyric acid receptors (GluR/GABAR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate and gamma-aminobutyric acid receptors (GluR/GABAR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call